Oral administration of recombinant <i>Bacillus subtilis</i> spores expressing <i>Helicobacter pylori</i> neutrophil‐activating protein suppresses peanut allergy via up‐regulation of Tregs

Abstract

Recombinant NAP spores successfully suppressed Th2 inflammation via the up-regulation of Tregs; this may serve as a novel therapeutic approach for treating food allergies.